TGFB1 and cervical cancer: Having demonstrated that miR-27a directly targets TGF-βRI and inhibits the TGF-β signaling pathway, we determined whether the miR-27a-agomir-mediated phenotypic changes of cervical cancer cells resulted from the suppressed TGF-β signaling.